CG
DPLO

Clinton Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Clinton Group’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-23,608
Closed -$297K – 1102
2016
Q4 		$297K Buy
23,608
+2,470
+12% +$46K 0.02% 694
2016
Q3 		$592K Buy
+21,138
New +$709K 0.03% 634

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Clinton Group's DPLO Position: Q1 2017 in Review

Clinton Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2017, closing a stake of 23,608 shares — an estimated $297K sold.

Clinton Group first reported a position in DPLO in Q3 2016 and held it in 2 quarters. The position peaked at $592K in Q3 2016. 155 funds tracked by Wall St. Rank hold DPLO as of Q1 2017.

  • Clinton Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2017 after selling out during the quarter.
  • Clinton Group sold 23,608 DIPLOMAT PHARMACY, INC. shares in Q1 2017, an estimated $297K.
  • Clinton Group first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2016 and held it in 2 quarters.
  • Clinton Group's DIPLOMAT PHARMACY, INC. position peaked at $592K in Q3 2016.
  • 155 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2017.

Based on Clinton Group's 13F filing for Q1 2017, filed 10 May 2017.